Medication-assisted therapy for opioid addiction

Journal of Food and Drug Analysis

Volumn 21, Issue 4 SUPPL., 2013, Pages

  Tai, Betty ^a   Saxon, Andrew J ^b,c   Ling, Walter ^d  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Buprenorphine; Chronic care model; Methadone; Opioid addiction

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE ANTAGONIST;

CONFERENCE PAPER; HUMAN IMMUNODEFICIENCY VIRUS; OPIATE ADDICTION; RISK REDUCTION; SUBSTANCE ABUSE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84897027418     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2013.09.023     Document Type: Conference Paper

References (11)

1. Volkow ND, Li TK. The neuroscience of addiction. Nat Neurosci 2005;8:1429-30.
2. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775-9.
3. Weiss RD, Potter JS, Fiellin DA, et al. Adjunctive counseling during brief and extended buprenorphineenaloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Arch Gen Psychiatry 2011;68:1238-46.
4. Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioidaddicted youth: A randomized trial. JAMA 2008;300:2003-11.
5. Tai B, Wu L, Clark H. Electronic health records: Essential tools in integrating substance abuse treatment with primary care. Subst Abuse Rehabil 2012;3:8.
6. Tai B, Volkow ND. Treatment for substance use disorder: Opportunities and challenges under the Affordable Care Act. Soc Work Public Health 2013;28:165-74.
7. Coleman K, Austin BT, Brach C, et al. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood) 2009;28:75-85.
8. Wagner EH. Chronic disease management: What will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2-4.
9. Ghitza UE, Wu LT, Tai B. Integrating substance abuse care with community diabetes care: Implications for research and clinical practice. Subst Abuse Rehabil 2013;4:3-10.
10. Crist RC, Clarke TK, Ang A, et al. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African Americans. Neuropsychopharmacology 2013;38:2003-10.
11. McLellan AT, Starrels JL, Tai B, et al. Can substance use disorders be managed using the chronic care model? Review and recommendations from a NIDA Consensus Group. Public Health Reviews 2013 in press.